Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

399
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
399
Long-term Depression01:03

Long-term Depression

2.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.7K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

176
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
176
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

122.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
122.1K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

231
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
231
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

841
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
841

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, tolerability, and pharmacokinetics of HL-300, a novel topical pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial.

Expert opinion on investigational drugs·2026
Same author

A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream (HZ-J001) in healthy Chinese subjects.

Frontiers in pharmacology·2026
Same author

Role of pharmacy education and pharmacy practice in developing pharmacists as researchers in China.

The International journal of pharmacy practice·2026
Same author

[Gender differences in acylcarnitine metabolism among patients with depression disorder].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2026
Same author

A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or Obesity.

Diabetes, obesity & metabolism·2026
Same author

Safety, pharmacokinetics, and sex hormone suppression of LY01021 versus relugolix: A single- and multiple-dose escalation study.

European journal of pharmacology·2026
Same journal

Association of neutrophil-to-prognostic nutritional index ratio with long-term mortality in acute myocardial infarction from Chinese and US cohorts.

Frontiers in nutrition·2026
Same journal

Milk fat globule membrane in early-life nutrition: composition, production, and biological effects on infant immune maturation, intestinal development, neurocognitive function, and growth.

Frontiers in nutrition·2026
Same journal

Research on volatile flavor substances and biological activities of different parts of <i>Allium schoenoprasum</i> L.

Frontiers in nutrition·2026
Same journal

Prognostic nutritional indices and long-term survival after endoscopic submucosal dissection for early gastric cancer in elderly patients: a systematic review and meta-analysis.

Frontiers in nutrition·2026
Same journal

Applying machine learning to associate clinical factors with malnutrition risk in peritoneal dialysis patients: an internally validated interpretable model.

Frontiers in nutrition·2026
Same journal

Multidimensional determinants of food insecurity among households in Somalia: evidence from the 2018/2019 Somalia health and demographic survey.

Frontiers in nutrition·2026
See all related articles

Related Experiment Video

Updated: Sep 28, 2025

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.2K

Carnitine and Depression.

Ting Liu1,2, Kunhong Deng3, Ying Xue1,2

  • 1Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Nutrition
|April 4, 2022
PubMed
Summary
This summary is machine-generated.

Acylcarnitines (ACs) show altered levels in depression patients, suggesting their potential as diagnostic biomarkers. Acetyl-L-carnitine supplementation may also offer new therapeutic strategies for depression.

Keywords:
acylcarnitinesbipolar disordercarnitinedepressionschizophrenia

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

213
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.8K

Related Experiment Videos

Last Updated: Sep 28, 2025

A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

21.2K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

213
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.8K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Psychiatry

Background:

  • Depression is a prevalent global mental health issue with insufficient understanding of its pathogenesis and treatment.
  • Carnitine, a naturally occurring substance, plays roles in various biological processes and has been linked to mental health conditions.
  • Previous research indicates altered acylcarnitine (ACs) levels in depressed individuals and potential benefits from acetyl-L-carnitine supplementation.

Purpose of the Study:

  • To review the role of acylcarnitines (ACs) in patients with depression.
  • To investigate the potential of ACs as diagnostic biomarkers for depression.
  • To explore novel therapeutic approaches for depression based on ACs.

Main Methods:

  • Literature review of studies investigating carnitine and its derivatives in depression.
  • Analysis of research on acylcarnitine levels in depressed patients versus controls.
  • Examination of studies on the therapeutic effects of acetyl-L-carnitine in depression.

Main Results:

  • Significant alterations in acylcarnitine (AC) levels are observed in individuals with depression compared to healthy controls.
  • Acetyl-L-carnitine supplementation has demonstrated positive effects in the treatment of depression.
  • ACs show promise as potential biomarkers for depression diagnosis.

Conclusions:

  • Acylcarnitines (ACs) are implicated in the pathophysiology of depression.
  • ACs may serve as valuable biomarkers for the diagnosis of depression.
  • Targeting carnitine metabolism could offer new avenues for depression treatment.